Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

Mice lacking the extracellular matrix protein tenascin-C showed a reduced ability to repair muscular damage compared to controls.

Hyderabad: India is emerging as a powerhouse in quantum technology, ranking as the second largest country in the world for ...

Transformative Growth Ahead for Immunotherapy Drugs as Precision Medicine, AI, and Biologics Propel Market Innovation and ...